Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation

Nils Erik Magnusson, Mads Hornum, Kaj Anker Jørgensen, Jesper Melchior Hansen, Claus Bistrup, Bo Feldt-Rasmussen, Allan Flyvbjerg

33 Citations (Scopus)

Abstract

Neutrophil gelatinase associated lipocalin (NGAL) is a biomarker of kidney injury. We examined plasma levels of NGAL in a cohort of 57 kidney allograft recipients (Tx group, 39 ± 13 years), a uraemic group of 40 patients remaining on the waiting list (47 ± 11 years) and a control group of 14 healthy subjects matched for age, sex and body mass index (BMI). The kidney graft recipients were studied at baseline before transplantation and 3 and 12 months after transplantation and the uraemic group at baseline and after 12 months.
Original languageEnglish
JournalB M C Nephrology
Volume13
Pages (from-to)8
Number of pages8
ISSN1471-2369
DOIs
Publication statusPublished - 2012

Keywords

  • Acute-Phase Proteins
  • Adult
  • Biological Markers
  • Female
  • Humans
  • Kidney Failure, Chronic
  • Kidney Function Tests
  • Kidney Transplantation
  • Lipocalins
  • Male
  • Middle Aged
  • Prospective Studies
  • Proto-Oncogene Proteins
  • Time Factors
  • Uremia

Fingerprint

Dive into the research topics of 'Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation'. Together they form a unique fingerprint.

Cite this